Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Essafi Benkhadir, Khadija ^a,c   Grosso, Sébastien ^a   Puissant, Alexandre ^a   Robert, Guillaume ^a   Essafi, Makram ^a   Deckert, Marcel ^a   Chamorey, Emmanuel ^b   Dassonville, Olivier ^b   Milano, Gérard ^b   Auberger, Patrick ^a   Pagès, Gilles ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; METHIONINE; TRANSCRIPTION FACTOR SP3; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME ACTIVITY; GENE FUNCTION; GENE INDUCTION; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUDE MOUSE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR CELL LINE; WESTERN BLOTTING;

MUS MUSCULUS;

EID: 84887212408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004478     Document Type: Article

References (34)

1. Sapetschnig A, Koch F, Rischitor G, Mennenga T, Suske G (2004) Complexity of translationally controlled transcription factor Sp3 isoform expression. J Biol Chem 279: 42095-42105.
2. Suske G (1999) The Sp-family of transcription factors. Gene 238: 291-300.
3. Black AR, Black JD, Azizkhan-Clifford J (2001) Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160.
4. Lou Z, O'Reilly S, Liang H, Maher VM, Sleight SD, et al. (2005) Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res 65: 1007-1017.
5. Wang L, Wei D, Huang S, Peng Z, Le X, et al. (2003) Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380.
6. Maurer GD, Leupold JH, Schewe DM, Biller T, Kates RE, et al. (2007) Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer. Clin Cancer Res 13: 1123-1132.
7. Deniaud E, Baguet J, Mathieu AL, Pages G, Marvel J, et al. (2006) Overexpression of Sp1 transcription factor induces apoptosis. Oncogene 25: 7096-7105.
8. Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, et al. (2003) Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci 23: 3597-3606.
9. Xu R, Zhang P, Huang J, Ge S, Lu J, et al. (2007) Sp1 and Sp3 regulate basal transcription of the survivin gene. Biochem Biophys Res Commun 356: 286-292.
10. Chintharlapalli S, Papineni S, Ramaiah SK, Safe S (2007) Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 67: 2816-2823.
11. Pages G (2007) Sp3-Mediated VEGF regulation is dependent on phosphorylation by extra-cellular signals regulated kinases (Erk). J Cell Physiol 213: 454-463.
12. Fujita E, Egashira J, Urase K, Kuida K, Momoi T (2001) Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ 8: 335-344.
13. Gartel AL, Goufman E, Najmahadi F, Tyner AL (2000) Sp1 and Sp3 activate p21 (WAF/CIP1) gene transcription in the caco-2 colon adenocarcinoma cell line. Oncogene 19: 5182-5188.
14. Abdelrahim M, Smith R 3rd, Burghardt R, Safe S (2004) Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 64: 6740-6749.
15. Kramps C, Strieder V, Sapetschnig A, Suske G, Lutz W (2004) E2F and Sp1/ Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. J Biol Chem 279: 5110-5117.
16. Onesto C, Hannoun-Levi JM, Chamorey E, Formento JL, Ramaioli A, et al. (2006) Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance. Br J Cancer 94: 1516-1523.
17. Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, et al. (2001) Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 61: 4143-4154.
18. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67: 11001-11011.
19. Zhang X, Li Y, Dai C, Yang J, Mundel P, et al. (2003) Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney. Am J Physiol Renal Physiol 284: F82-94.
20. Geiser AG, Busam KJ, Kim SJ, Lafyatis R, O'Reilly MA, et al. (1993) Regulation of the transforming growth factor-beta 1 and -beta 3 promoters by transcription factor Sp1. Gene 129: 223-228.
21. Sakamoto KM, Bardeleben C, Yates KE, Raines MA, Golde DW, et al. (1991) 5′ upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. Oncogene 6: 867-871.
22. Im HJ, Pittelkow MR, Kumar R (2002) Divergent regulation of the growth-promoting gene IEX-1 by the p53 tumor suppressor and Sp1. J Biol Chem 277: 14612-14621.
23. Shi W, Inoue M, Minami M, Takeda K, Matsumoto M, et al. (1996) The genomic structure and chromosomal localization of the mouse STAT3 gene. Int Immunol 8: 1205-1211.
24. Koutsodontis G, Moustakas A, Kardassis D (2002) The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF-1/Cip1 gene promoter. Biochemistry 41: 12771-12784.
25. Pang H, Miranda K, Fine A (1998) Sp3 regulates fas expression in lung epithelial cells. Biochem J 333 (Pt 1): 209-213.
26. Chirakkal H, Leech SH, Brookes KE, Prais AL, Waby JS, et al. (2006) Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene 25: 7192-7200.
27. Nishiyama J, Yi X, Venkatachalam MA, Dong Z (2001) cDNA cloning and promoter analysis of rat caspase-9. Biochem J 360: 49-56.
28. Dong L, Wang W, Wang F, Stoner M, Reed JC, et al. (1999) Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J Biol Chem 274: 32099-32107.
29. Zhan Q, Carrier F, Fornace AJ Jr (1993) Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 13: 4242-4250.
30. Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K, Motoyama N (2002) FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem 277: 26729-26732.
31. Harroch S, Gothelf Y, Revel M, Chebath J (1995) 5′ upstream sequences of MyD88, an IL-6 primary response gene in M1 cells: detection of functional IRF-1 and Stat factors binding sites. Nucleic Acids Res 23: 3539-3546.
32. Marchetti S, Gimond C, Roux D, Gothie E, Pouyssegur J, et al. (2004) Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice. J Cell Physiol 199: 441-450.
33. Luciano F, Ricci JE, Herrant M, Bertolotto C, Mari B, et al. (2002) T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma. Leukemia 16: 700-707.
34. Bertolotto C, Ricci JE, Luciano F, Mari B, Chambard JC, et al. (2000) Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-FOS promoter transcriptional activity. J Biol Chem 275: 12941-12947.